Showing posts with label Complicated Urinary Tract Infections. Show all posts
Showing posts with label Complicated Urinary Tract Infections. Show all posts
Saturday, October 31, 2026

FDA Approves Zaynich (cefepime and zidebactam) for the Treatment of Complicated Urinary Tract Infections

›
In continuation of my update on  cefepime cefepime Zidebactam FDA approved Zaynich (cefepime and zidebactam), a novel intravenous antibiotic...
Wednesday, January 28, 2026

FDA Approves Contepo (fosfomycin) for Injection for the Treatment of Complicated Urinary Tract Infections

›
The U.S. Food and Drug Administration (FDA) has approved Contepo (fosfomycin) for injection for the treatment of patients 18 years of age an...
Tuesday, September 10, 2024

FDA Approves Exblifep (cefepime/enmetazobactam) for the Treatment of Complicated Urinary Tract Infections,

›
Allecra Therapeutics (“Allecra”), a biopharmaceutical company developing novel therapies to combat antibiotic resistance, announced today th...
Thursday, December 30, 2021

Spero Therapeutics Submits New Drug Application for Tebipenem HBr for the Treatment of Complicated Urinary Tract Infections including Pyelonephritis

›
    Spero Therapeutics, Inc. announced the submission of a new drug application (NDA) to the U.S. Food and Drug Administration (FDA), seekin...
Tuesday, March 3, 2020

FDA Approves Fetroja (cefiderocol) for the Treatment of Complicated Urinary Tract Infections

›
The U.S. Food and Drug Administration approved Fetroja (cefiderocol), an antibacterial drug for treatment of patients 18 years of age ...